What We're Reading: Page 255
Industry reads hand-picked by our editors
Aug 21, 2018
-
The New York Times
A Chinese pharmacist found out he had cancer. Then he vanished.
-
The Boston Globe
Organogenesis will become a public company again
-
The Wall Street Journal
The woman who has a plan for Wall Street to help cure blindness
-
Associated Press
AbbVie donates $100M to Ronald McDonald House Charities
Aug 20, 2018
-
The New York Times
This drug is safe and effective. Wait. Compared with what?
-
Reuters
U.S. health secretary says agency has power to eliminate drug rebates
-
Kaiser Health News
The man who sold America on vitamin D — and profited in the process
-
CNBC
An unlikely winner in the long-running bull market: Health insurers
-
Undark
How peddlers of 'food-grade' hydrogen peroxide exploit the sick and desperate
Aug 17, 2018
-
The New York Times
Bleak new estimates in drug epidemic: A record 72,000 overdose deaths in 2017
-
Reuters
China sacks top official over vaccine scandal, firm may de-list
-
Genetic Engineering & Biotechnology News
Can transcriptomics help find the right time to administer chemotherapy?
-
Business Insider
Mylan quietly made an acquisition for almost half a billion dollars in July that it didn't tell investors about right away
Aug 16, 2018
Aug 15, 2018
Aug 14, 2018
Aug 13, 2018
-
The New York Times
Nebraska plans first execution in 21 years. Not so fast, drug company says.
-
The Wall Street Journal
China’s drugs problem spells opportunity for pharma giants
-
Reuters
Roundup cancer verdict sends Bayer shares sliding
Previous
